Xaira Therapeutics Funding: $1B Raised, Series A (2024)
Xaira Therapeutics is a Biotech company based in San Francisco, California. It has raised $1B in total funding. Latest round: Series A.
Xaira Therapeutics funding overview
Xaira Therapeutics is a Biotech company based in San Francisco, California. Xaira Therapeutics has raised $1B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is a Series A announced in April 2024. The round record for Xaira Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Arch Venture Partners, Foresite Labs. 2 distinct backers are named across the disclosed rounds.
Xaira Therapeutics at a glance
Total raised
$1B
Latest round
Series A
Latest round date
April 2024
Industry
Biotech
Headquarters
San Francisco, California
Notable investors
Arch Venture Partners, Foresite Labs
Frequently asked about Xaira Therapeutics funding
How much has Xaira Therapeutics raised?
Xaira Therapeutics has raised $1B in total disclosed funding across the rounds on record.
Who has invested in Xaira Therapeutics?
Arch Venture Partners, Foresite Labs are named among the investors backing Xaira Therapeutics.
What was the latest Xaira Therapeutics funding round?
The most recent disclosed round is a Series A, announced in April 2024.
Where is Xaira Therapeutics based?
Xaira Therapeutics is based in San Francisco, California.
What sector does Xaira Therapeutics operate in?
Xaira Therapeutics is tracked under Biotech from San Francisco, California, with $1B in disclosed funding.
When did Xaira Therapeutics last raise?
The last disclosed Xaira Therapeutics round closed in April 2024 at Series A.
Every Xaira Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in San Francisco at a similar stage.
